Literature DB >> 27777186

Bullous pemphigoid during ustekinumab therapy in a psoriatic patient.

Nahide Onsun1, Kadriye Sallahoglu1, Didem Dizman1, Özlem Su1, Zeynep Tosuner2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27777186     DOI： 10.1684/ejd.2016.2888

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  8 in total

Review 1.  Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Am J Clin Dermatol       Date:  2022-08-14       Impact factor: 6.233

Review 2.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

3.  Bullous pemphigoid induced by ustekinumab: a case report.

Authors:  Marta Marin; Natalia Alzueta; Marta Castresana; Ana Gascón; María Pío
Journal:  Eur J Hosp Pharm       Date:  2019-05-30

4.  A Systematic Review of Drug-Induced Pemphigoid.

Authors:  Matthew J Verheyden; Asli Bilgic; Dédée F Murrell
Journal:  Acta Derm Venereol       Date:  2020-08-17       Impact factor: 3.875

Review 5.  Guselkumab-associated bullous pemphigoid in a psoriasis patient: A case report and review of the literature.

Authors:  Martina Burlando; Niccolò Capurro; Astrid Herzum; Emanuele Cozzani; Aurora Parodi
Journal:  Dermatol Ther       Date:  2021-11-30       Impact factor: 3.858

6.  New-onset autoantibody-mediated nephritis during ustekinumab therapy for psoriasis in patients with and without prior systemic lupus erythematosus.

Authors:  Ayida Al Khalili; Leah Scott; Jan P Dutz
Journal:  JAAD Case Rep       Date:  2019-08-02

7.  TH17/IL23 cytokine gene polymorphisms in bullous pemphigoid.

Authors:  Pardis-Sadat Tabatabaei-Panah; Hamideh Moravvej; Sahel Aghaei; Maryam Akbari; Sakineh Rajabi; Atena Kia; Elaheh Ebrahimi; Zahra Sadaf; Alireza Atoon; Nasim Behravesh; Ralf J Ludwig; Reza Akbarzadeh
Journal:  Mol Genet Genomic Med       Date:  2020-12-19       Impact factor: 2.183

Review 8.  Alternative uses of ustekinumab for non-indicated dermatological conditions: a systematic review.

Authors:  Sahil Rawal; Sara Kianian; William Guo; Jocellie Marquez; Marissa Ayasse; Katherine A Siamas; Yoojin Lee; Joann Salvemini
Journal:  Arch Dermatol Res       Date:  2021-06-22       Impact factor: 3.017
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.